TABLE 1.
Demographics of patients with Delta (N = 163) and Omicron (N = 171)
| Delta, n (%) | Omicron, n (%) | |
|---|---|---|
| Sex | ||
| Female | 98 (60.9%) | 91 (53.2%) |
| Male | 63 (39.1%) | 80 (46.8%) |
| Race | ||
| White | 79 (47.9%) | 80 (44.9%) |
| Black/African American | 73 (44.2%) | 75 (42.1%) |
| Asian | 3 (1.8%) | 8 (4.5%) |
| Other | 10 (6.1%) | 11 (6.2%) |
| Refuse to Answer | 0 (0%) | 4 (2.3%) |
| Ethnicity | ||
| Hispanic | 12 (7.4%) | 26 (15.2%) |
| Non-Hispanic | 149 (92.6%) | 144 (84.2%) |
| Refuse to answer | 0 (0%) | 1 (0.6%) |
| Vaccine status | ||
| Unvaccinated/not fully vaccinated | 65 (40.9%) | 83 (48.5%) |
| Fully vaccinated/boosted | 94 (59.1%) | 88 (51.5%) |
| Days since last vaccine | ||
| Within the last 90 days | 17 (17.7%) | 41 (43.1%) |
| Between 91 and 180 days | 22 (22.9%) | 16 (16.8%) |
| Between 181 and 270 days | 52 (54.2%) | 28 (29.5%) |
| More than 270 days | 5 (5.2%) | 10 (10.5%) |
| Symptom status | ||
| Asymptomatic | 5 (3.1%) | 1 (0.6%) |
| Symptomatic | 156 (96.9%) | 170 (99.4%) |
| Symptom duration | ||
| Symptoms for at most 3 days | 36 (23.1%) | 132 (77.7%) |
| Symptoms for between 4 and 7 days | 80 (51.3%) | 38 (22.3%) |
| Symptoms for more than 7 days | 40 (25.6%) | 0 (0%) |